Max Healthcare Institute Limited (NSE:MAXHEALTH)
India · Delayed Price · Currency is INR 1,246.00
0.00 (0.00%)
Aug 1, 2025, 3:30 PM IST
Max Healthcare Institute Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 70,285 | 54,060 | 45,626 | 39,366 | 25,080 | Upgrade |
| 70,285 | 54,060 | 45,626 | 39,366 | 25,080 | Upgrade | |
Revenue Growth (YoY) | 30.01% | 18.49% | 15.90% | 56.96% | 136.82% | Upgrade |
Cost of Revenue | 26,511 | 20,529 | 17,314 | 17,481 | 12,324 | Upgrade |
Gross Profit | 43,774 | 33,531 | 28,312 | 21,885 | 12,755 | Upgrade |
Selling, General & Admin | 14,747 | 11,169 | 9,863 | 8,729 | 5,657 | Upgrade |
Other Operating Expenses | 10,157 | 7,159 | 5,887 | 3,365 | 2,927 | Upgrade |
Operating Expenses | 28,499 | 20,778 | 18,072 | 14,305 | 10,325 | Upgrade |
Operating Income | 15,275 | 12,753 | 10,240 | 7,580 | 2,431 | Upgrade |
Interest Expense | -1,488 | -445.6 | -713.2 | -900.1 | -1,710 | Upgrade |
Interest & Investment Income | 1,172 | 1,562 | 1,124 | 750.9 | 767.3 | Upgrade |
Earnings From Equity Investments | - | - | - | - | -230.5 | Upgrade |
Currency Exchange Gain (Loss) | -7 | 3 | -2.4 | -3.4 | 178.8 | Upgrade |
Other Non Operating Income (Expenses) | 204.4 | 41.6 | 86.7 | 207.3 | 67.4 | Upgrade |
EBT Excluding Unusual Items | 15,158 | 13,914 | 10,735 | 7,634 | 1,504 | Upgrade |
Merger & Restructuring Charges | - | - | - | -90.3 | -377.8 | Upgrade |
Gain (Loss) on Sale of Assets | 1.1 | 4.5 | 13.3 | -30.6 | -2.4 | Upgrade |
Asset Writedown | - | - | - | -0.6 | -81.4 | Upgrade |
Other Unusual Items | -1,095 | -265.4 | -111.2 | -123.8 | -1,959 | Upgrade |
Pretax Income | 14,064 | 13,653 | 10,637 | 7,389 | -917 | Upgrade |
Income Tax Expense | 3,305 | 3,077 | -397.9 | 1,339 | 458.5 | Upgrade |
Earnings From Continuing Operations | 10,759 | 10,576 | 11,035 | 6,051 | -1,376 | Upgrade |
Net Income to Company | 10,759 | 10,576 | 11,035 | 6,051 | -1,376 | Upgrade |
Net Income | 10,759 | 10,576 | 11,035 | 6,051 | -1,376 | Upgrade |
Net Income to Common | 10,759 | 10,576 | 11,035 | 6,051 | -1,376 | Upgrade |
Net Income Growth | 1.73% | -4.16% | 82.38% | - | - | Upgrade |
Shares Outstanding (Basic) | 972 | 972 | 970 | 967 | 863 | Upgrade |
Shares Outstanding (Diluted) | 977 | 975 | 972 | 969 | 863 | Upgrade |
Shares Change (YoY) | 0.20% | 0.39% | 0.24% | 12.30% | 47.77% | Upgrade |
EPS (Basic) | 11.07 | 10.89 | 11.38 | 6.25 | -1.59 | Upgrade |
EPS (Diluted) | 11.01 | 10.84 | 11.36 | 6.24 | -1.59 | Upgrade |
EPS Growth | 1.57% | -4.58% | 82.05% | - | - | Upgrade |
Free Cash Flow | 4,938 | 3,357 | 9,485 | 1,872 | -5.6 | Upgrade |
Free Cash Flow Per Share | 5.05 | 3.44 | 9.76 | 1.93 | -0.01 | Upgrade |
Dividend Per Share | 1.500 | 1.500 | 1.000 | - | - | Upgrade |
Dividend Growth | - | 50.00% | - | - | - | Upgrade |
Gross Margin | 62.28% | 62.02% | 62.05% | 55.59% | 50.86% | Upgrade |
Operating Margin | 21.73% | 23.59% | 22.44% | 19.25% | 9.69% | Upgrade |
Profit Margin | 15.31% | 19.56% | 24.19% | 15.37% | -5.49% | Upgrade |
Free Cash Flow Margin | 7.03% | 6.21% | 20.79% | 4.75% | -0.02% | Upgrade |
EBITDA | 18,312 | 14,819 | 12,226 | 9,465 | 3,896 | Upgrade |
EBITDA Margin | 26.05% | 27.41% | 26.80% | 24.04% | 15.53% | Upgrade |
D&A For EBITDA | 3,037 | 2,066 | 1,986 | 1,886 | 1,465 | Upgrade |
EBIT | 15,275 | 12,753 | 10,240 | 7,580 | 2,431 | Upgrade |
EBIT Margin | 21.73% | 23.59% | 22.44% | 19.25% | 9.69% | Upgrade |
Effective Tax Rate | 23.50% | 22.54% | - | 18.12% | - | Upgrade |
Revenue as Reported | 71,841 | 55,830 | 47,018 | 40,588 | 26,194 | Upgrade |
Advertising Expenses | - | - | - | 446.2 | 167.5 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.